Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials

Predicting tumor response prior to starting anti-epidermal growth factor receptor (EGFR) antibody therapy would benefit patients with advanced/metastatic colorectal cancer (mCRC). The present study investigated the association between efficacy of cetuximab treatment and gene polymorphisms of fragmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: Maeda, Hiromichi, Hazama, Shoichi, Iwamoto, Shigeyoshi, Oba, Koji, Tsunedomi, Ryouichi, Okayama, Naoko, Suehiro, Yutaka, Yamasaki, Takahiro, Nakagami, Yuki, Suzuki, Nobuaki, Nagano, Hiroaki, Sakamoto, Junichi, Mishima, Hideyuki, Nagata, Naoki
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781779/
https://ncbi.nlm.nih.gov/pubmed/31611963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10787
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados